(Q50722957)

18 March 2018

title

High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma. (English)

1 reference

18 March 2018

1 reference

3

Ylermi Soini

1 reference

18 March 2018

Simi Santala

1

1 reference

18 March 2018

Anne Talvensaari-Mattila

series ordinal

2

1 reference

18 March 2018

Maria Honkavuori-Toivola

series ordinal

4

1 reference

18 March 2018

Markku Santala

series ordinal

5

1 reference

18 March 2018

publication date

12 February 2014

1 reference

18 March 2018

published in

Tumor Biology

1 reference

18 March 2018

volume

35

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

page(s)

5395-5399

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-1703-9

exact match

0 references

cites work

Revised FIGO staging for carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Current concepts in the pathology and epigenetics of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Molecular characteristics and risk factors in endometrial cancer: what are the treatment and preventative strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Cell cyclins: triggering elements of cancer or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Cyclin A in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

E- and A-type cyclins as markers for cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Progressive derailment of cell cycle regulators in endometrial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Whether to target single or multiple CDKs for therapy? That is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1703-9

Cyclin-dependent kinase modulators and cancer therapy

21 January 2018

1 reference

12 December 2020

Liquid-based preparation for endometrial cytology--usefulness for predicting the prognosis of endometrial carcinoma preoperatively.

1 reference

12 December 2020

Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma

1 reference

12 December 2020

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

1 reference

12 December 2020

Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator

1 reference

12 December 2020

10.1007/S13277-014-1703-9

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

24519066

1 reference

18 March 2018